drugset / Trial / NCT00835718

A Study of MK0594 in Patients With Alcohol Dependence (0594-020)

NCT00835718 ↗

Phase 2 Terminated 162 enrolled Vyne Therapeutics Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A study in patients with alcohol dependence to see if MK0594 is safe and effective in maintaining absence of heavy drinking over a 12-week treatment period.

Timeline

Start
2009-02-27
Primary completion
2010-03-11
Completion
2010-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Serlopitant Small molecule 1 mg Oral
Subject Serlopitant Small molecule 5 mg Oral

Indications